Pseudotumor Cerebri and Hypothyroidism

Oliver W. Press, Paul W Ladenson

Research output: Contribution to journalArticle

Abstract

A 38-year-old obese woman with concurrent hypothyroidism and pseudotumor cerebri was monitored with serial thyroid function tests and CSF pressure determinations during levothyroxine sodium replacement therapy. Following normalization of the patient's thyroid status, assessed by both clinical and chemical indexes (serum thyroxine level, 1.5 to 11.0 μg/dL; serum thyrotropin level, 128 to 1.5 μU/mL), intracranial hypertension persisted for more than four months. After weight loss, acetazolamide therapy, and intermittent CSF drainage failed to produce remission, glucocorticoid therapy was associated with prompt, sustained resolution of the pseudotumor cerebri. Contrary to previous reports, this patient's clinical course suggests that thyroid hormone deficiency and pseudotumor cerebri are not causally related.

Original languageEnglish (US)
Pages (from-to)167-168
Number of pages2
JournalArchives of Internal Medicine
Volume143
Issue number1
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Pseudotumor Cerebri
Hypothyroidism
Thyroxine
Thyroid Function Tests
Acetazolamide
Intracranial Hypertension
Thyrotropin
Serum
Thyroid Hormones
Glucocorticoids
Weight Loss
Drainage
Thyroid Gland
Therapeutics
Pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Pseudotumor Cerebri and Hypothyroidism. / Press, Oliver W.; Ladenson, Paul W.

In: Archives of Internal Medicine, Vol. 143, No. 1, 1983, p. 167-168.

Research output: Contribution to journalArticle

Press, Oliver W. ; Ladenson, Paul W. / Pseudotumor Cerebri and Hypothyroidism. In: Archives of Internal Medicine. 1983 ; Vol. 143, No. 1. pp. 167-168.
@article{25cae400529e47e4bd598015a1307a13,
title = "Pseudotumor Cerebri and Hypothyroidism",
abstract = "A 38-year-old obese woman with concurrent hypothyroidism and pseudotumor cerebri was monitored with serial thyroid function tests and CSF pressure determinations during levothyroxine sodium replacement therapy. Following normalization of the patient's thyroid status, assessed by both clinical and chemical indexes (serum thyroxine level, 1.5 to 11.0 μg/dL; serum thyrotropin level, 128 to 1.5 μU/mL), intracranial hypertension persisted for more than four months. After weight loss, acetazolamide therapy, and intermittent CSF drainage failed to produce remission, glucocorticoid therapy was associated with prompt, sustained resolution of the pseudotumor cerebri. Contrary to previous reports, this patient's clinical course suggests that thyroid hormone deficiency and pseudotumor cerebri are not causally related.",
author = "Press, {Oliver W.} and Ladenson, {Paul W}",
year = "1983",
doi = "10.1001/archinte.1983.00350010179035",
language = "English (US)",
volume = "143",
pages = "167--168",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Pseudotumor Cerebri and Hypothyroidism

AU - Press, Oliver W.

AU - Ladenson, Paul W

PY - 1983

Y1 - 1983

N2 - A 38-year-old obese woman with concurrent hypothyroidism and pseudotumor cerebri was monitored with serial thyroid function tests and CSF pressure determinations during levothyroxine sodium replacement therapy. Following normalization of the patient's thyroid status, assessed by both clinical and chemical indexes (serum thyroxine level, 1.5 to 11.0 μg/dL; serum thyrotropin level, 128 to 1.5 μU/mL), intracranial hypertension persisted for more than four months. After weight loss, acetazolamide therapy, and intermittent CSF drainage failed to produce remission, glucocorticoid therapy was associated with prompt, sustained resolution of the pseudotumor cerebri. Contrary to previous reports, this patient's clinical course suggests that thyroid hormone deficiency and pseudotumor cerebri are not causally related.

AB - A 38-year-old obese woman with concurrent hypothyroidism and pseudotumor cerebri was monitored with serial thyroid function tests and CSF pressure determinations during levothyroxine sodium replacement therapy. Following normalization of the patient's thyroid status, assessed by both clinical and chemical indexes (serum thyroxine level, 1.5 to 11.0 μg/dL; serum thyrotropin level, 128 to 1.5 μU/mL), intracranial hypertension persisted for more than four months. After weight loss, acetazolamide therapy, and intermittent CSF drainage failed to produce remission, glucocorticoid therapy was associated with prompt, sustained resolution of the pseudotumor cerebri. Contrary to previous reports, this patient's clinical course suggests that thyroid hormone deficiency and pseudotumor cerebri are not causally related.

UR - http://www.scopus.com/inward/record.url?scp=0020700214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020700214&partnerID=8YFLogxK

U2 - 10.1001/archinte.1983.00350010179035

DO - 10.1001/archinte.1983.00350010179035

M3 - Article

C2 - 6849597

AN - SCOPUS:0020700214

VL - 143

SP - 167

EP - 168

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 1

ER -